- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Odisha Govt proposes Rs 1500 crore Bulk Drug Park at Gopalpur
Bhubaneswar: The Odisha government on Friday accorded in-principle approval to a proposal for setting up a Bulk Drug Park within the Tata Steel Special Economic Zone (SEZ) at Gopalpur in Ganjam district, a senior official said.
The project proposal was discussed at a high-level meeting chaired by Chief Secretary A K Tripathy. The proposed project is part of the state government''s aim of creating employment opportunities through industrialization in the non-mineral sector.
Industries secretary Hemant Sharma presented the feasibility report along with the technical and financial details of the park.
Considering the potentiality of a bulk drug park in the state, the chief secretary directed the State Implementing Agency (SIA) to set up a Special Purpose Vehicle (SPV) and work out the detailed proposal within a fortnight, Sharma said.
"The proposal for setting up the park in Tata SEZ at Gopalpur received in principle approval in the meeting," Sharma said, adding that the location of the proposed drug park spot is well connected with port and railway.
It is less than two hours from the Biju Patnaik International Airport in Bhubaneswar and the existing airstrip at Gopalpur could also be utilized for required communication. The land is well connected with NH-16 which is considered as the spine for the proposed Odisha Economic Corridor, he said.
The land parcel of around 1000 acres required for the park, is available in the Tata SEZ in Gopalpur. "The SPV will be formed involving IDCO as the lead promoter and TSSZEL (Tata Group) and co-promoter to carry forward the project proposal, a statement released by the chief secretarys office said.
Sharma said that the park would have all the advanced infrastructure facilities including central effluent treatment plant, solid waste management, warehousing, dedicated power distribution system, steam generation and distribution system, common cooling system, advanced testing laboratories, centre of excellence, technology business incubator and intellectual property right services.
The cost of the infrastructure development in the park was estimated around Rs 1,500 crore, he said, adding that the project would be implemented through the financial support of both the Central and state government.
The proposed park would create employment opportunities for around 5,000 people, Sharma said.
The chief secretary directed the Industries department to send the proposal to the Government of India within September 25.
Read also: COVID19: Govt launches eight immunity-boosting nutraceutical products under PMBJP
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751